Page last updated: 2024-10-30

mechlorethamine and Dementias, Transmissible

mechlorethamine has been researched along with Dementias, Transmissible in 1 studies

nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.

Research Excerpts

ExcerptRelevanceReference
"Mechlorethamine treatment significantly decreased in vitro amplification of PrP(Sc) in the highly efficient protein misfolding cyclic amplification system."1.37Alkylating antitumor drug mechlorethamine conceals a structured PrP domain and inhibits in vitro prion amplification. ( Bi, H; Shimoji, M; Wang, GX; Wang, Y; Wong, J; Xiao, X; Yuan, J; Zhou, X; Zou, WQ, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhou, X1
Bi, H1
Wong, J1
Shimoji, M1
Wang, Y1
Yuan, J1
Xiao, X1
Wang, GX1
Zou, WQ1

Other Studies

1 other study available for mechlorethamine and Dementias, Transmissible

ArticleYear
Alkylating antitumor drug mechlorethamine conceals a structured PrP domain and inhibits in vitro prion amplification.
    Journal of toxicology and environmental health. Part A, 2011, Volume: 74, Issue:22-24

    Topics: Animals; Antineoplastic Agents, Alkylating; Epitopes; Humans; Mechlorethamine; Prion Diseases; Prote

2011